Latest Biomarker Stories
IRVING, Texas, May 27, 2015 /PRNewswire/ -- Caris Life Sciences®, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced it has appointed
DUNEDIN, New Zealand and HERSHEY, Pa., May 26, 2015 /PRNewswire/ -- Newly published research demonstrates that Cxbladder out performs other non-invasive bladder cancer diagnostics, announced
Collaboration between patient advocates, academic researchers, and industry scientists provides deeper knowledge of Duchenne biology and potential new approaches to diagnosis and treatment
Virginia Cancer Specialists Joins Caris Centers of Excellence for Precision Medicine Network to Help Develop Guidelines and Standards of Care for Tumor Profiling IRVING, Texas, May
SAN DIEGO, May 20, 2015 /PRNewswire/ -- Cypher Genomics, Inc., a leading genome informatics company, today announced a collaboration with Celgene Corporation to apply Cypher's Coral(TM )technology
ORLANDO, Fla., May 14, 2015 /PRNewswire/ -- MEDITE Cancer Diagnostics, Inc., ("Company," OTCQB symbol: "MDIT") specializing in the development, manufacturing and marketing of molecular biomarkers
According to a new study, researchers in the United Kingdom have found evidence indicating that leprosy spread to England from Scandinavia in the 5th or 6th century.
AUSTIN, Texas, May 14, 2015 /PRNewswire/ -- Vermillion, Inc.
Research Demonstrates Clinical Utility of Caris Molecular Intelligence and Advances Molecular Understanding of Cancer to Enable the Delivery of Precision Medicine IRVING, Texas, May 14, 2015
MONTREAL, May 13, 2015 /PRNewswire/ - The Montreal Heart Institute (MHI) today announced a collaboration with AstraZeneca, to search the genomes of up to 80,000 patients for genes associated
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.
More Images (2 images) »